1. The excretion of 75Se and stable Se in bile and urine was measured in four steers during 6 h after intravenous injections of 75Se as either selenit: or selenate containing either 5 or 5000 pg carrier Se.
The bovine liver plays a significant role in the metabolism of selenium. When small amounts of '5Se0,2-(5-20 pg Se) are injected intravenously the liver removes at least 40%, attaches it to protein and releases it into the plasma 30-60 min later (Symonds et al. 1981) . Se given as selenate is metabolized less rapidly and a greater proportion is excreted in urine. Some of the Se removed by the liver is excreted in bile although there appears to be a species difference in the extent to which this occurs. In the non-ruminant (rat) approximately 5.8%/h of an intravenous dose of 76Se was excreted in bile (Imbach & Sternberg, 1967) while in the sheep the maximum activity 3-4 h after dosing was approximately 0*0012%/ml bile (Dejneka et al. 1979) . Assuming a bile flow-rate of 60ml/h (Harrison, 1962) the total amount secreted during 96 h was less than 2%.
It is possible that, as with the trace elements copper and manganese, the concentration of Se in bile increases when the plasma concentration of the element is increased. Such an effect could explain the differences observed in the excretion rate of Se from the rat and sheep. A study was therefore made in four steers to compare the clearance of different quantities of Se (5 pg or 5.300 pg), given either as Na,75Se0, or Na,75Se0,, from plasma and their excretion in urine and bile. The results confirm that a much greater proportion of injected 75Se is excreted in urine than in bile, that selenite is more readily metabolized than selenate at low carrier levels and that only a small proportion of injected Se is excreted in bile, although the proportion is increased when 5000 pg Se is injected.
MATERIALS A N D METHODS

Animals
Four Angus x Friesian steers (A, B, C and D), weighing between 400 and 500 kg were used. Each had had its duodenum surgically altered to allow bile to be collected and its rate of flow measured. The procedure entailed isolating that section of the duodenum where the common bile duct entered and diverting the bile entering this section back to the duodenum at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19810057 via a re-entrant cannula (Symonds et al. 1982) . The steers were not used until at least 6-8 weeks after surgery.
Experimental procedure
Approximately 25 pCi 75Se as either NaZ7jSe0, or NaZ7jSe0, were given as a single injection (9 g sodium chloride/l) was infused into the isolated section of duodenum at 9 ml/min through a small cannula. Bile flow-rate was calculated as the difference between the total volume of fluid collected and the volume of saline infused. Urine was collected in a container suspended below the steer's abdomen.
Analytical methods
The amount of 75Se in urine, plasma and bile was determined by measuring the radioactivity present in weighed samples in an NE 81 12 y-spectrometer (Nuclear Enterprises) at a counting efficiency of approximately 75%. The percentage of the injected dose present was calculated using standards prepared from known dilutions of the dose.
During each infusion 1 % of the volume of urine and bile passed during each collection period was pooled. The stable Se content of these pooled samples and of selected plasma samples was measured by the method used by Little et al. (1979) . The exponential components making up the pattern of clearance of 'jSe from plasma were calculated by stripping off each component to obtain the best fit for up to three components (a, p and
Expression of urinary 75Se values
The frequency of micturition varied considerably among the steers. In order to determine the average patterns of excretion of 75Se in urine after the administration of the different salts and different amounts of carrier, the cumulative excretion of 75Se during the 6 h after each dose was plotted graphically for each steer from the measured values. The accumulative excretion was then calculated from the graph for each 30 rnin period. The average value of excretion for each 30 min period for all animals for each salt and each carrier amount was then calculated and plotted (Fig. 3 ).
Y).
R E S U L T S
The efect of the amount of carrier Se Clearance of 7sseo,2-from plasma. The values presented in Fig. 1 are the means for all steers, normalized by expressing the results for each steer as a percentage of the activity present in its plasma at 2 min after injection. The mean ( f SE) percentage dose/l plasma at 2 rnin after injection of 5 pg and 5000 ,ug of Se was 3.28 (f0.22) and 2-99 ( f 0.13) respectively. The amount of carrier had little effect on the rate of clearance during the first 30 min, the 75Se concentration decreasing to approximately 30% of the concentration at 2 min. When 5 pg Se was injected the 76Se concentration in plasma then increased during the next 75 rnin to reach just over 60% of the concentration at 2 min and then decreased slowly with a mean 9 of 19.3 h (Fig. 1) . When 5000pg of Se were injected there was no increase in plasma radioactivity after 30 min and by 5 h after injection the radioactivity had decreased to approximatell 18% of that at 2 min.
The mean 4 of both a and p components of clearance were similar for both carrier levels and are given in Table 1 . A. thrd (7) component with a 5 of 693 and 371 rnin respectively was present in steers C and D after 5000 pg while in steers A and B plasma radioactivity increased very slightly.
Clearance of 75Se042-.from plasma. The values presented are the means of two observations on steer A and one on steer B and normalized as previously described for 75Se032-values. The mean 1: f SE) percentage dose/l plasma at 2 min after dosing with either 5 or 5000 pg was 2-65 ( f 0-20) and 2.52 (& 0.22) respectively. During the first 45 rnin the rate of disappearance of :5Se was similar for both carrier levels and its concentration decreased to 40% of the concentration at 2 min. Thereafter, after dosing with 5 pg there was a slow increase to 45 % by 4 h. After 5000 pg, clearance continued exponentially throughout the 6 h period.
Values for 9 of the com:3onents of clearance after 5 and 5000 pg are given in Table 1 .
The a component could nct be measured in steer A2. The other components were similar to the components of clearance of 75Se032-with the exception that the / l component after 5 pg Se was over twice as long as that after 5 pg Se as Se032-. Excretion of Se and 75Se in urine. Fig. 3 shows the mean cumulative excretion of 75Se in urine for both salts and carrier amounts, calculated as described on p. 488. Tables 2 and  3 give the total 75Se and stable Se excreted in urine during the 6 h after dosing. The smallest loss occurred after 5 p g 76:3e0,2-was given. After 5 p g 75Se0,2-17% was excreted and approximately 23% was excreted after both 5000pg doses. Urinary excretion of 75Se continued for longer after both 76Se042-doses and after the 5000 pg 75Se032-dose. The at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19810057 principal loss of 75Se after 5 p g 76Se032-was in the first sample of urine passed. After injection of 5000 pg carrier Se, irrespective of the salt given, the percentage excreted in urine was similar to the percentage of radioactivity excreted, approximately 25% of the dose. Excretion of Se and 7sSe in bile. When 5pg carrier as either salt was given a similar percentage (0.2%) of the 75Se was excreted in bile during the 6 h. After 5000 pg the percentage excreted increased to 1.94 and 0436 for 75Se032-and 76Se0,2-respectively. 9 e was detectable in the bile within 10 min of dosing (Fig. 4) . The greatest increase in excretion rate occurred when 5000 pg Se as Se032-was given.
It was not possible to calculate the absolute increase in stable Se excreted after dosing because of insufficient quantitative values for normal rates of loss before dosing. The values in parentheses in Tables 2 and 3 are for the ratio, concentration of Se in bile (and urine) after dosing: the concentration of Se immediately before dosing. An increase in concentration occurred only when 5000 pg Se as SeO,%-was injected.
Changes in stable Se concentrations in plasma. The stable Se concentration in the plasma of four steers was determined on the predose plasma sample and on plasma samples taken at 2, 30 and 360 min after dosing. No detectable change was produced by 5 pg Se, the mean concentration at 0,2,30 and 360 rnin being 44,49,46 and 48 ng/ml respectively. After 5000 pg Se the corresponding values for the mean concentrations for were 34, 175, 98 and 62 ng/ml and for !k13,2-41,153,88 and 43 ng/ml. The mean plasma specific activity in the plasma samples taken 2 min after the 5 pg dose were 3.9 and 3.3 times greater than that present 2 min after th: injection of 5000 pg !k03z-and SeO,z-respectively.
at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19810057 
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Period after dose (min) Fig. 4 . Excretion of 7sSe in the bile (% dose) during 6 h after the intravenous injection of Na,76Se0, containing 5 pg ( . --. ) or 5000 pg (.---a) carrier Se and Na25Se0, containing approximately
DISCUSSION
The results demonstrate that: (1) the biliary route is not important in the control of loss of Se from the body even when systemic plasma Se concentrations are elevated. The amounts excreted in bile represent on average the clearance of Se from less than 10 ml plasma/min at normal plasma Se concentrations; (2) the amount of carrier Se and the salt used affect the pattern of clearance of ' S S e from plasma; (3) the SeO,z-form is more readily incorporated into body tissues at low carrier levels, a much greater percentage of injected at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19810057
Se042-being excreted in urine; (4) at high carrier levels similar percentages of the two salts are excreted in urine. The normal concentrations of Se in plasma were between 34 and 48 ng/ml. The 5 pg dose was therefore equivalent t 3 the amount of Se contained in approximately 100 ml plasma (approximately one three-hundredth of the plasma volume) whereas the 5000 pg dose would represent that contained in 100 1 plasma or approximately three to four times the plasma volume. The experiment5 using a dose of 5pg Se therefore provided values more representative of the normal kinetics of Se homoeostasis. They indicated that the SeO,*-form was more readily incorporated into tissues, only 0.2% being excreted in bile and only 6% in urine. Selenate was less readily incorporated, there was a much greater and more prolonged loss in urine and the @ component of plasma clearance had a much longer 4 (36-67 min) after 5 pg was given. When 5000 pg carrier Se was used the clearance patterns from plasma and excretion in urine were similar for each salt; approximately 22 and 24% of the Se032-and Se042-doses appearing in urine during the 6 h observation period. The increased excretion in urine was prolonged beyond 6 h.
The rapid increase in plasma ' 9 e radioactivity between 30 and 60 min after injection of 5 pg Se as 75Se0,2-is due to the release of protein-bound 75Se from the liver into the systemic circulation (Symonds el al. 1981) . Approximately 40% of such low carrier doses of Se03e-are removed by the liver. The absence of an increase in 75Se in plasma after 30 min when 5000 pg was given was probably due to the liver removing a much smaller amount of the Se injected at a lower (approximately )) specific activity. These factors would result in the amount of 75Se attached to the subsequently released protein being insufficient to cause any detectable increase in tbt: declining systemic plasma radioactivity. Thus, the plasma clearance pattern when large amounts of carrier Se are given does not represent the physiological norm. In the rat, Imbach & Sternberg (1967) observed a double exponential clearance of intravenouslyinjected 75Se032-. The a component had a 4 of 2.9 min, similar to that in the steers, while their @ component (4 19-5 h) was much longer than even the mean y component for both salts (465 min) but similar to the component of clearance of the bound 75Se appearing after 5 pg of Se as SeO,*-were given. Although there may be species variations in Se hoinoeostasis the differences observed are more likely to be due to the amount of carrier Se given. Imbach & Sternberg (1967) gave doses of 130pg Se/kg body-weight which were approximately 13000 times greater on a body-weight basis than the 5 pg dose given to the steers. These observations emphasize the need to ensure that the amount of carrier used in radioisotope studies should be as small as possible, particularly when plasma concentrations of the element under study are normally low.
